AI assistant
Egetis Therapeutics Major Shareholding Notification 2019
3152_iss_2019-11-04_f66fd94b-1f37-4569-ba7e-59fb82f059c2.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Egetis Therapeutics AB (publ)
Holder
Fjärde AP-fonden
Instrument
| Instrument | Aktier |
|---|---|
| Before the transaction | |
| Shares | 3,200,000 |
| Voting rights | 3,200,000 |
| Transaction | |
| Reason for major shareholding notification Other | |
| Date | 31/10/2019 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 3,200,000 |
| Directly held voting rights | 3,200,000 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 5.98 % |
| Directly held voting rights | 5.98 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.98 % | 3,200,000 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 5.98 % | 3,200,000 |
| Group total holdings |
||
| Voting rights | 3,200,000 | |
| Percentage of voting rights 5.98 | ||
| Notes (other relevant informations according to law) | ||
| Flaggning görs eftersom bolaget noteras på huvudlistan. | ||
| Published | ||
| 04/11/2019 11:43 | ||
Contact Name Jannis Kitsakis Phone 070-6038023 Email [email protected]
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25